Clinical Trial

Epidemiology of Narcolepsy Type 1 and Type 2 in Spain

Study acronym: HYPNOS
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 15, 2026 (before its estimated July 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
The main purpose of this study is to find out how many people in Spain have been diagnosed with narcolepsy type 1 and type 2, and how many new participants are diagnosed each year. Narcolepsy is a rare sleep disorder that causes excessive daytime sleepiness. The researchers will look at medical records from hospitals across Spain to count participants with these conditions and understand patterns in diagnosis over time.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-05-30 -> 2026-07-31 2026-05-16
minor Completion pushed: 2026-05-30 -> 2026-07-31 2026-05-16
Trial Details
NCT Number NCT07299097
Lead Sponsor Takeda
Conditions Narcolepsy Type 1, Narcolepsy Type 2
Enrollment 100 participants
Start Date 2025-12-02
Primary Completion 2026-07-31 (estimated)
Study Completion 2026-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-15